missing translation for 'onlineSavingsMsg'
Läs mer

STEMCELL Technologies AKT Inhibitor VIII

Produktkod. 17110152
Encompass_Preferred
Change view
Klicka för att se tillgängliga alternativ
Kvantitet:
1 mg
10 mg
Förpackningsstorlek:
1mg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Produktkod. Kvantitet unitSize
17110152 1 mg 1mg
17120152 10 mg -
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Denna artikel kan inte returneras. Se returpolicy
Produktkod. 17110152 Leverantör STEMCELL Technologies Leverantörsnummer 72942

Please to purchase this item. Need a web account? Register with us today!

Denna artikel kan inte returneras. Se returpolicy

PI3K/AKT pathway inhibitor; Inhibits AKT1, AKT2, and AKT3

  • AKT Inhibitor VIII is a cell-permeable, allosteric inhibitor of all three forms of the kinase AKT (AKT1, AKT2, and AKT3) with IC50 values of 58, 210, and 2,200 nM, respectively (Lindsley et al.; Calleja et al.) It displays good selectivity against a panel of 70 other kinases with micromolar inhibition against some kinases, such as calcium/calmodulin-dependent protein kinase 1 and smooth muscle myosin light-chain kinase (Logie et al.)
  • Sensitizes prostate tumor and cervical carcinoma cells to apoptotic stimuli (DeFeo-Jones et al.)
  • Blocks mitosis and inhibits migration of HeLa cells (Jo et al.)
  • Reduces insulin-dependent gene repression in liver cells leading to reduced insulin sensitivity (Logie et al.)

Specifikationer

CAS 612847-09-3
Synonym AKTi-1/2; AKT 1/2 inhibitor
Kvantitet 1 mg
Molekylformel C34H29N7O
Renhet ≥98%
Produkttitel
Välj ett problem

Genom att klicka på Skicka bekräftar du att du kan bli kontaktad av Fisher Scientific angående feedbacken du har lämnat i detta formulär. Vi kommer inte att dela din information för andra ändamål. All kontaktinformation som tillhandahålls ska också underhållas i enlighet med vår Sekretesspolicy.